Clinical characteristics and efficacy in non-small cell lung cancer patients with EGFR exon 20 insertion and EGFR amplification

被引：0
|
作者：
Gao, X.
Wei, X-W.
Wu, Y-L.
Zhou, Q.
机构：
[1] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
501P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
    Gao, Xin
    Wei, Xue-Wu
    Zheng, Ming-Ying
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Zhong, Wen-Zhao
    Yang, Jin-Ji
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5822 - +
  • [2] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [3] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Morita, Chie
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Masuda, Ken
    Matsumoto, Yuji
    Shinno, Yuki
    Yagishita, Shigehiro
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Motoi, Noriko
    Yatabe, Yasushi
    Ohe, Yuichiro
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Chie Morita
    Tatsuya Yoshida
    Masayuki Shirasawa
    Ken Masuda
    Yuji Matsumoto
    Yuki Shinno
    Shigehiro Yagishita
    Yusuke Okuma
    Yasushi Goto
    Hidehito Horinouchi
    Noboru Yamamoto
    Noriko Motoi
    Yasushi Yatabe
    Yuichiro Ohe
    [J]. Scientific Reports, 11
  • [5] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
  • [6] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [7] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
    Miyanaga, A.
    Akagi, K.
    Takeuchi, S.
    Kurimoto, F.
    Iijima, Y.
    Yoshino, N.
    Mikami, I.
    Akiyama, H.
    Sakai, H.
    [J]. LUNG CANCER, 2009, 64 : S54 - S54
  • [8] Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
    van Veggel, B.
    van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    De Langen, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [9] Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non-small cell lung cancer
    Pan, Binyang
    Liang, Jiaqi
    Shi, Haochun
    Rao, Kungeng
    Guo, Weigang
    Zhan, Cheng
    [J]. THORACIC CANCER, 2023, 14 (33) : 3247 - 3258
  • [10] New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations
    David, Gil-Sierra Manuel
    del Pilar, Briceno-Casado Maria
    Cristina, Moreno-Ramos
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 934 - 943
12345